Hours of Operation:
Mon: 12:00 PM-7:00 PM
Tues: 10:00 AM-4:00 PM
Wed: 10:00 AM-4:00 PM
Thurs: 10:00 AM-4:00 PM
Fri: 9:00 AM-6:00 PM
Sat: 10:00 AM-5:00 PM
Sun: 10:00 AM-4:00 PM
Fuel your Life.
Why Am I Not Losing Weight on a GLP-1?
So, if you’re taking a GLP-1 and the scale hasn’t moved the way you expected, it does not necessarily mean the medication has failed. It also doesn’t automatically mean that you need a higher dose.
Instead, it may be time to look more closely at your dose, treatment duration, nutrition, activity, sleep, other medications, medical conditions, and overall response to therapy.
Why GLP-1 Weight Loss Varies From Person to Person
One of the most important things to understand about GLP-1 weight loss is that response naturally varies from person to person.
Researchers are still learning why two people taking the same medication at similar doses can experience very different results. The answer probably involves a complicated combination of genetics, metabolism, appetite regulation, body composition, starting weight, eating behavior, medical history, sleep, physical activity, and environmental factors.
Large studies have identified certain population-level trends. For example, research with semaglutide has found differences in average weight-loss response according to factors such as sex and starting BMI. In the SELECT trial, women experienced greater average percentage weight loss than men, while baseline BMI was also associated with modest differences in response (Ryan et al., Nature Medicine, 2024).
However, these are averages across thousands of people—not predictions of what will happen to any individual.
A slower-than-expected response should therefore be viewed as a reason to evaluate your treatment plan, rather than a reason to panic or immediately increase your medication.
7 Common Reasons You May Not Be Losing Weight on a GLP-1
1. You May Not Have Reached Your Maintenance Dose Yet
Many GLP-1 medications are intentionally started at a low dose and gradually increased over time. This process is known as dose titration.
For semaglutide used for chronic weight management, for example, clinical trials gradually increased the dose over approximately 16 weeks before reaching the target maintenance dose. The gradual approach helps the body adjust and can reduce gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation.
Because the early doses are primarily intended to help your body tolerate treatment, some people experience only modest weight loss during the first several weeks.
That means comparing your results after four, eight, or even twelve weeks with someone who has been taking a maintenance dose for a year can be misleading.
GLP-1 weight loss takes time. In major semaglutide trials, weight continued to decline for many months before eventually beginning to level off. In the STEP 5 study, average weight loss progressed until approximately week 60 before reaching a plateau that was largely maintained through two years of treatment (Garvey et al., Nature Medicine, 2022).
2. Missed or Inconsistent Doses Can Affect Your Results
Consistency matters with GLP-1 treatment.
Frequently missing doses, delaying injections, stopping and restarting medication, or having extended gaps in treatment can interfere with the consistent medication exposure needed to support appetite regulation and weight management.
This doesn’t mean that one delayed dose will suddenly eliminate your progress. But repeated interruptions can make it more difficult to evaluate whether the medication is truly effective for you.
If you’ve been inconsistent because of side effects, medication availability, cost, travel, or another issue, talk with your healthcare provider rather than attempting to compensate by changing your dose on your own.
3. Your Eating Patterns May Not Have Changed Enough
GLP-1 medications can make it easier to eat less by reducing hunger, increasing satiety, and helping some people feel satisfied with smaller portions. But they do not make nutrition irrelevant.
Medical weight-loss medications are generally used alongside nutrition and lifestyle changes, rather than as a replacement for them.
It is still possible to consume enough calories to maintain your current weight while taking a GLP-1, particularly through:
- Frequent snacking
- High-calorie beverages
- Alcohol
- Calorie-dense restaurant meals
- Large portions despite reduced hunger
- Highly processed foods that are easy to overconsume
If your weight has stopped changing, reviewing what and how much you’re eating can sometimes reveal patterns that aren’t obvious day to day.
The goal isn’t necessarily extreme calorie restriction. In fact, overly restrictive eating can make it difficult to consume adequate protein, vitamins, minerals, fiber, and other nutrients. Instead, the focus should generally be on creating a sustainable eating pattern that supports your medical weight-management goals.
4. Your Physical Activity or Muscle Mass May Be Affecting Progress
Exercise is about more than simply burning calories.
During significant weight loss, the body can lose both fat and lean tissue. Maintaining muscle is important because skeletal muscle supports strength, mobility, metabolic health, and daily energy expenditure.
That is one reason resistance training and adequate dietary protein can be important parts of a comprehensive GLP-1 weight-management program.
If physical activity has decreased substantially—especially because you’re eating less and therefore feeling less energetic—it may contribute to a slowdown in progress.
A balanced program may include regular walking or cardiovascular activity together with resistance exercise appropriate for your health and fitness level.
5. Another Medication May Be Working Against Your Weight-Loss Goals
GLP-1 medications don’t operate in isolation. Other medications can affect appetite, metabolism, fluid retention, insulin levels, or body weight.
Certain medications used for conditions such as depression, anxiety, mood disorders, seizures, diabetes, inflammation, and other health concerns may be associated with weight gain in some people.
That doesn’t mean you should stop an important medication to lose weight. Instead, your healthcare provider can review your medication list and determine whether any of your prescriptions may be influencing your progress or whether appropriate alternatives exist.
Never discontinue or change a prescription medication without discussing it with the clinician who manages it.
6. Sleep, Stress, or an Underlying Medical Condition May Be Playing a Role
Weight regulation is influenced by much more than food intake.
Several health and lifestyle factors can make weight management more difficult, including:
- Insufficient or poor-quality sleep
- Untreated sleep apnea
- Thyroid disorders
- Chronic stress
- Hormonal or metabolic conditions
- Emotional eating
- Binge-eating behaviors
- Reduced physical activity
For example, someone taking their medication consistently while getting five hours of sleep each night and experiencing untreated sleep apnea may have a very different weight-management experience than someone with healthy sleep and activity patterns.
This is one reason effective medical weight management should look at the whole person, rather than simply increasing medication every time the number on the scale slows down.
7. You May Have Reached a GLP-1 Weight Loss Plateau
A GLP-1 weight loss plateau is not necessarily the same thing as treatment failure.
As body weight decreases, the body adapts. A smaller body generally requires fewer calories to maintain than a larger one, and metabolic and appetite-related adaptations can gradually narrow the energy deficit that originally produced weight loss.
This means that someone can continue taking the same medication, eating similarly, and exercising regularly while seeing the rate of weight loss gradually slow.
Clinical studies demonstrate this clearly. In the STEP 5 semaglutide study, average weight loss eventually plateaued after roughly 60 weeks and then remained relatively stable through week 104.
More recent clinical guidance also recognizes that weight-management medications are frequently used as long-term therapy when they are effective and well tolerated, in part because maintaining previously lost weight is an important treatment outcome—not a failure to continue losing indefinitely.
In other words, if you lost a substantial amount of weight and have maintained that loss, the medication may still be providing meaningful benefit even though the scale is no longer moving every week.
What Is a GLP-1 Nonresponder?
You may have heard the term GLP-1 nonresponder.
In obesity medicine, losing at least 5% of starting body weight is commonly used as one benchmark for a clinically meaningful response. Major trials show that most people taking newer GLP-1-based therapies achieve this threshold, but not everyone does.
For example, approximately 86% of participants assigned to semaglutide in the STEP 1 trial lost at least 5% of their starting body weight by week 68. That means a meaningful minority did not reach the 5% threshold despite being part of a tightly controlled clinical trial.
The STEP 5 trial similarly demonstrated substantial variation between individuals even though average weight loss was significant.
Being a slower responder—or even a nonresponder to one medication—does not necessarily mean that medical weight management cannot work for you. It means your provider may need to reconsider the treatment strategy after accounting for dose, duration, adherence, side effects, eating patterns, medical conditions, and other factors.
Does a Weight-Loss Plateau Mean You Need a Higher GLP-1 Dose?
Not necessarily.
Dose is only one part of the picture.
If you’re still titrating toward an appropriate maintenance dose, your healthcare provider may recommend continuing the planned titration schedule. But if you’re already taking an established maintenance dose, automatically increasing medication may not address the actual reason your progress has slowed.
Your provider may first evaluate:
- How long you’ve been taking the medication
- Whether doses have been taken consistently
- Your total percentage of weight lost
- Whether your appetite has changed
- Your current eating and drinking patterns
- Protein intake and resistance exercise
- Sleep quality and possible sleep apnea
- Other prescription medications
- Medical or hormonal conditions
- Whether you’re experiencing a normal weight-loss plateau
A thoughtful evaluation can be much more useful than simply asking, “Can we increase my dose?”
How Long Should You Give a GLP-1 Medication to Work?
This is one of the most common questions people have when they begin treatment.
There isn’t one timeline that applies to everyone because the answer depends on the medication, prescribed dose, titration schedule, side effects, treatment consistency, and your individual response.
What is clear from clinical trials is that the full effect of GLP-1-based weight-management therapy generally develops over months, not days or weeks.
Current obesity-management guidance recommends periodically evaluating both the effectiveness and safety of weight-management medications. If progress remains limited after an adequate trial at an appropriate dose, your healthcare provider can reassess whether continuing the same treatment makes sense or whether another strategy should be considered.
What Should You Do If Your GLP-1 Isn't Working as Expected?
If you’re frustrated with your results, try not to judge the effectiveness of treatment from a single weigh-in—or even a single week.
Instead, look at the bigger picture.
Your medical weight-management provider can review your weight trend, waist measurements, appetite changes, medication tolerance, nutrition, physical activity, sleep, laboratory results, current prescriptions, and other health factors to determine what may be limiting progress.
Depending on the findings, the next step might involve adjusting nutrition, increasing resistance exercise, improving treatment consistency, addressing sleep or another medical condition, changing the medication strategy, or simply allowing more time for treatment to work.
Do not increase, decrease, stop, or restart a GLP-1 medication without discussing the change with your prescribing healthcare professional.
The Bottom Line: Slower GLP-1 Weight Loss Doesn't Automatically Mean Failure
GLP-1 medications such as semaglutide and related treatments can be powerful tools for medical weight management, but they are not identical in every person.
Some people experience dramatic weight loss. Others lose weight steadily but more slowly. Some reach a plateau after significant progress, and a smaller group experiences relatively little weight loss despite treatment.
If you’re not losing weight on a GLP-1, the most important question usually isn’t simply, “Do I need more medication?”
A better question is:
“What is limiting my response, and what part of my treatment plan should we evaluate next?”
That approach allows you and your healthcare provider to make decisions based on your individual response, health, and goals rather than comparing your progress with someone else’s experience.
References
Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021. Garvey WT, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022. Ryan DH, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nature Medicine. 2024. American Diabetes Association. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes.Frequently Asked Questions
Why am I not losing weight on semaglutide?
Can semaglutide stop working for weight loss?
Why am I not losing weight on tirzepatide?
How much weight should I lose on a GLP-1?
Is it normal to stop losing weight on a GLP-1?
Should I increase my GLP-1 dose if I'm not losing weight?
